secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001493152-24-036060
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech amends CEO/COO employment: CEO salary $650k plus $100k stock
---------------------------------------------------------------------------

- CEO Equels: cash salary reduced to $650,000, plus $100,000 in restricted shares for one year ending Sept 11, 2025.
- COO Rodino: base salary $375,000 plus $50,000 in shares; period corrected to one year ending Aug 12, 2025.
- Amendment corrects prior duration error in August 2024 compensation changes for both officers.
- Shares valued at 100% of Sept 10, 2024 closing price; compensation committee approved the revisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/0001493152-24-036060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer